Contractor
THE INSTITUTE FOR CANCER RESEARCH
- UEI
- FF1XVJMDYVR1
- Parent UEI
- FF1XVJMDYVR1
- Resolved by
- uei
- Confidence
- 1.000
Active from Apr 7, 2026 to Jul 21, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N91019D00022 EO 14398 PREVENT PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS | Department of Health and Human Services | — | Jul 21, 2026 | — |
| 75N91022F00002 BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER | Department of Health and Human Services | PA | Jul 7, 2026 | $1,237,620 |
| 75N92E21P00142 THE ELNITSKI LAB IS PURCHASING NORMAL, LIVER, AND PROSTATE CANCER PATIENT PLASMA.[21-004028] | Department of Health and Human Services | PA | Jul 6, 2026 | $0 |
| 75N91024D00003 PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM | Department of Health and Human Services | — | Apr 28, 2026 | — |
| 75N91022F00001 BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION | Department of Health and Human Services | PA | May 12, 2026 | $2,051,148 |
| 75N91023F00003 PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA | Department of Health and Human Services | PA | Apr 7, 2026 | $1,199,274 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier FF1XVJMDYVR1, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.